Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland

BACKGROUND: Tirbanibulin 1% ointment is a new treatment for actinic keratosis (AK) on the face or scalp. A health economic model was developed as part of a submission to the Scottish Medicines Consortium to evaluate the cost-effectiveness of tirbanibulin compared to the most frequently prescribed tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dymond, Amy, Green, Will, Edwards, Mary, Pont, Maria Angeles Lopez, Gupta, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170011/
https://www.ncbi.nlm.nih.gov/pubmed/37012513
http://dx.doi.org/10.1007/s41669-023-00410-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170011/
https://www.ncbi.nlm.nih.gov/pubmed/37012513
http://dx.doi.org/10.1007/s41669-023-00410-5

Ejemplares similares